Jackson Acquisition Co II

Jackson Acquisition Co II(JACS)股票分析

$10.855

+0.005 (+0.05%)收盤時

Loading chart…
最高
10.920
開盤
10.920
成交量加權均價
10.88
成交量
1.01K
市值
—
最低
10.850
成交金額
10.94K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Jackson Acquisition Company II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business by concentrating its efforts in identifying businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company neither engaged in any operations nor generated any revenue.

AI 分析 of Jackson Acquisition Co II (JACS)

持有

Jackson Acquisition Company II (JACS) is currently trading at $10.85, which is very close to its 52-week high of $10.87, indicating limited upside potential. The RSI is at 57.63, suggesting that the stock is neither overbought nor oversold, which is a neutral indicator. However, the forward P/E ratio is 0, indicating a lack of expected earnings growth, which raises concerns about future profitability. The stock has shown a 5-day change of +0.28% and a year-to-date change of +4.13%, reflecting modest performance. The main risk is the current ratio, which has dropped to 0.77, indicating potential liquidity issues. Therefore, while the stock shows some stability, the lack of growth indicators and the liquidity risk suggest that it may be prudent to hold rather than buy at this time.

估值指標

Jackson Acquisition Co II(JACS)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

合理
5 年均值 P/S
0.12
目前P/S
0.00
高估
1.23
低估
-0.99

Alphio AI 對 JACS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%JACS

$14.19

情境價格

基

基準

基準 · 50%JACS

$12.49

情境價格

悲

悲觀

悲觀 · 25%JACS

$10.64

情境價格

持有 JACS 的大戶

L

Linden Advisors LP

+ 持有JACS

+61.02%

3個月報酬率

G

Glazer Capital, LLC

+ 持有JACS

+3.19%

3個月報酬率

W

W. R. Berkley Corporation

+ 持有JACS

-1.34%

3個月報酬率

W

Wolverine Asset Management, LLC

+ 持有JACS

-16.12%

3個月報酬率

JACS 常見問題 —— 由 Alphio AI 解答

Jackson Acquisition Company II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business by concentrating its efforts in identifying businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company neither engaged in any operations nor generated any revenue. It operates in the Financials sector.

Jackson Acquisition Company II (JACS) is currently trading at $10.85, which is very close to its 52-week high of $10.87, indicating limited upside potential. The RSI is at 57.63, suggesting that the stock is neither overbought nor oversold, which is a neutral indicator. However, the forward P/E ratio is 0, indicating a lack of expected earnings growth, which raises concerns about future profitability. The stock has shown a 5-day change of +0.28% and a year-to-date change of +4.13%, reflecting modest performance. The main risk is the current ratio, which has dropped to 0.77, indicating potential liquidity issues. Therefore, while the stock shows some stability, the lack of growth indicators and the liquidity risk suggest that it may be prudent to hold rather than buy at this time.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易